We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
-11.47%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$186M
AUM Growth
-$94.7M
Cap. Flow
-$67.3M
Cap. Flow %
-36.29%
Top 10 Hldgs %
37.92%
Holding
69
New
7
Increased
10
Reduced
25
Closed
21

Top Buys

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$6.04M
2
DHR icon
Danaher
DHR
+$4.61M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$3.66M
4
ELAN icon
Elanco Animal Health
ELAN
+$2.74M
5
SNN icon
Smith & Nephew
SNN
+$2.73M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$8.69M
2
AET
Aetna Inc
AET
+$7.1M
3
ALGN icon
Align Technology
ALGN
+$6.85M
4
CELG
Celgene Corp
CELG
+$4.47M
5
DGX icon
Quest Diagnostics
DGX
+$4.32M

Sector Composition

Rank Sector Weight
1 Healthcare 90.94%
2 Energy 2.02%
3 Financials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ABT icon
1
Abbott
ABT
$182B
$8.32M 4.48%
115,000
– –
BSX icon
2
Boston Scientific
BSX
$71.1B
$7.78M 4.19%
220,000
-15,000
-6% -$544K
WCG
3
DELISTED
Wellcare Health Plans, Inc.
WCG
$7.67M 4.14%
32,500
+2,500
+8% +$670K
CI icon
4
Cigna
CI
$72.4B
$7.6M 4.09%
40,000
– –
MRK icon
5
Merck
MRK
$316B
$7.26M 3.91%
99,560
-26,200
-21% -$1.85M
UNH icon
6
UnitedHealth
UNH
$370B
$6.97M 3.76%
28,000
+3,000
+12% +$792K
ISRG icon
7
Intuitive Surgical
ISRG
$130B
$6.46M 3.48%
40,500
+9,000
+29% +$1.53M
LLY icon
8
Eli Lilly
LLY
$995B
$6.37M 3.43%
55,000
-15,000
-21% -$1.68M
BIIB icon
9
Biogen
BIIB
$30.8B
$6.02M 3.24%
20,000
+2,500
+14% +$798K
ELV icon
10
Elevance Health
ELV
$82B
$5.91M 3.19%
22,500
-5,000
-18% -$1.37M
VRTX icon
11
Vertex Pharmaceuticals
VRTX
$121B
$5.8M 3.13%
35,000
– –
HUM icon
12
Humana
HUM
$43.5B
$5.73M 3.09%
20,000
-5,300
-21% -$1.68M
SYK icon
13
Stryker
SYK
$129B
$5.49M 2.96%
35,000
+5,000
+17% +$836K
XBI icon
14
State Street SPDR S&P Biotech ETF
XBI
$9.92B
$5.38M 2.9%
+75,000
New +$6.04M
AZN icon
15
AstraZeneca
AZN
$241B
$5.14M 2.77%
67,700
+5,200
+8% +$406K
BMRN icon
16
BioMarin Pharmaceuticals
BMRN
$11.7B
$4.68M 2.52%
55,000
– –
UHS icon
17
Universal Health Services
UHS
$10.2B
$4.66M 2.51%
40,000
-15,000
-27% -$1.89M
DHR icon
18
Danaher
DHR
$137B
$4.64M 2.5%
+50,760
New +$4.61M
ILMN icon
19
Illumina
ILMN
$30.7B
$4.5M 2.43%
15,420
– –
HCA icon
20
HCA Healthcare
HCA
$86.8B
$4.36M 2.35%
35,000
-20,000
-36% -$2.68M
WMGI
21
DELISTED
Wright Medical Group Inc
WMGI
$4.02M 2.17%
147,801
+7,801
+6% +$216K
BAX icon
22
Baxter International
BAX
$14.7B
$3.95M 2.13%
60,000
-20,000
-25% -$1.34M
QGEN icon
23
Qiagen
QGEN
$8.73B
$3.82M 2.06%
104,491
+24,331
+30% +$904K
LHCG
24
DELISTED
LHC Group LLC
LHCG
$3.75M 2.02%
40,000
+5,000
+14% +$478K
REGN icon
25
Regeneron Pharmaceuticals
REGN
$78.3B
$3.73M 2.01%
+10,000
New +$3.66M
1
2 3

Similar funds

RSF
Rik Saylor Financial Fairfield, Ohio $132M AUM 16.04% 1-Year Est. Return
VF
Visa Foundation San Francisco, California $132M AUM 14.62% 1-Year Est. Return
AFP
ATX Financial Planning Austin, Texas $132M AUM
GCM
Graver Capital Management Columbus, Ohio $132M AUM 16.79% 1-Year Est. Return
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return

Sivik Global Healthcare's Q4 2018 Portfolio in Review

As of Q4 2018, Sivik Global Healthcare held 69 positions worth $186M, down 34% from $280M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Sivik Global Healthcare withdrew a net $67.3M in Q4 2018, closing 21 positions and reducing 25 holdings. Its most notable exit was Bristol-Myers Squibb, an estimated $8.69M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 91% of assets, down from 91% a quarter earlier, followed by Energy and Financials.

Against the trend, Sivik Global Healthcare opened a new position in State Street SPDR S&P Biotech ETF worth $5.38M.

  • Sivik Global Healthcare's largest Q4 2018 buy was State Street SPDR S&P Biotech ETF: 75,000 shares worth $5.38M.
  • Sivik Global Healthcare added most to Agilent Technologies in Q4 2018, an estimated $2.16M increase.
  • Sivik Global Healthcare's biggest Q4 2018 reduction was GW Pharmaceuticals Plc American Depositary Shares, cutting an estimated $2.95M.
  • Sivik Global Healthcare fully exited Bristol-Myers Squibb in Q4 2018, selling an estimated $8.69M.
  • Sivik Global Healthcare's ten largest holdings make up 38% of its $186M portfolio in Q4 2018.
  • Sivik Global Healthcare opened 7 new positions and closed 21 in Q4 2018.
  • Sivik Global Healthcare's portfolio value fell 34% quarter-over-quarter to $186M.

Based on Sivik Global Healthcare's 13F filing for Q4 2018, filed 12 Feb 2019.